Vivos Enters Major Agreement with Philadelphia Dental Group to Offer Breakthrough Treatment for Obstructive Sleep Apnea (OSA)
SmileKrafter’s in Allentown becomes the first of 40 Philadelphia area dental offices to offer revolutionary treatment of OSA for adults, children
Philadelphia and Denver (February 20, 2018) – Vivos, a world leader in the treatment of obstructive sleep apnea (OSA), today announced that it has entered into an exclusive multiyear agreement with Dr. Bhaskar Savani who owns and operates 40 large dental practices in the greater Philadelphia area, with more than 500K patients of record. The first such practice to offer the Vivos System will be the SmileKrafter’s office in Allentown. Five more local offices managed by Dr. Savani will begin offering the Vivos System in the next few months.
The Vivos System is a breakthrough technology and treatment for OSA and may be the first viable long-term solution to address a major root cause of the condition: an underdeveloped or obstructed airway. While the vast majority of OSA solutions treat the symptoms through either pressure or force, the Vivos appliance gently remodels the upper airway by gradually developing/repositioning the jaws, thus restoring healthy sleep and breathing. While other OSA treatment modalities, such as CPAP, require lifetime use and nightly wear, the Vivos System treatment typically lasts 12 to 24 months, and can allow some patients to avoid further clinical intervention.
“In my judgement, the Vivos System is a game-changer for our doctors and patients. For the first time, we will actually be able to see patients restored to full vitality and wellness as their airways are enhanced by this treatment. We have tens of thousands of our patients on CPAP machines and other devices that only treat the symptoms, and we’re out to change that,” said Dr. Savani. “By offering this technology to our patients here in the Philadelphia area, we expect to significantly impact the lives of tens of thousands as we eliminate the need for lifelong nightly treatment with CPAP or mandibular advancement.”
Vivos’ agreement with Dr. Savani could represent annual revenues in excess of $10 million at full implementation for Vivos alone.
“Dr. Savani and other dentists and health care professionals across the country are rapidly coming to recognize the unique capabilities the Vivos System offers for their patients suffering from sleep apnea – and the results have been phenomenal already,” said Kirk Huntsman, CEO, Vivos. “In fact, thousands of patients are already experiencing the benefits this revolutionary technology offers, without the invasive or uncomfortable treatments they would otherwise have to undertake nightly for the rest of their lives.”
For more information about Vivos, please click here.
Media Contact: Shannon Michael, SnappConner PR, email@example.com
Founded in 2016, Vivos Therapeutics combines breakthrough technology for specially designed oral appliances with proprietary clinical protocols for obstructive sleep apnea (OSA) treatment that can restore and enhance the human airway. Because its patented FDA Class I and II medical devices are thought to be the first treatment that addresses the root causes of OSA, Vivos can improve the airway so that further clinical intervention may no longer be required in some cases. Other treatments for this insidious and dangerous condition require lifetime treatment, which has a significant impact on U.S. healthcare costs. Because the Vivos System is all-natural, non-invasive and non-pharmaceutical, many more patients will be able to receive treatment from the 750+ (and growing) independent providers who have been trained and certified in the Vivos methodology and who have already treated more than 8,000 patients. The company also is creating Vivos Breathing Wellness Centers in major metro areas, working with licensed and trained local medical and dental professionals. For more information, visit vivoslife.com.